Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide causes weight loss by mimicking a gut hormone called GLP-1, which signals to your brain that you are full, slows the rate at which food leaves your stomach, and gradually reduces how much you want to eat in the first place. Most people find the change isn't dramatic on day one; it builds over weeks. These are prescription-only medicines, so a clinician assesses whether they are appropriate before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the moment about 20 minutes into a meal when you put your fork down because you've had enough. That signal comes partly from GLP-1, a hormone released by cells in your gut when food arrives. It travels to the hypothalamus, the brain region that manages appetite, and tells it: full now, stop eating.
Semaglutide is a synthetic version of that hormone, engineered to last far longer in the body than the natural form. The natural GLP-1 molecule breaks down in minutes. Semaglutide, injected once weekly, sustains that fullness signal around the clock. People often describe the experience as simply not thinking about food as much, and if you've wondered whether that sustained signal can also affect your sleep or keep you awake at night, it's a question worth looking into. Hunger doesn't disappear, but it becomes quieter, a background note rather than a constant demand.
This matters because it explains why weight loss on semaglutide isn't about gritting your teeth through hunger. The mechanism acts upstream of willpower. For a fuller look at how this process plays out in practice, this overview of semaglutide's mechanism goes into more detail on each pathway.
The second part of the picture is gastric emptying. GLP-1 receptors sit in the gut wall as well as the brain, and activating them tells the stomach to hold its contents back a little longer before passing them into the small intestine. Food stays with you longer. A modest lunch that would previously have left you hunting the biscuit tin by 3pm can feel genuinely sufficient for hours.
This is also why nausea is the most commonly reported side effect, particularly in the early weeks of treatment. The stomach is adjusting to a new pace. The NHS medicines page for semaglutide gives a plain-English rundown of what to expect and which symptoms warrant a call to your prescriber. Most people find the GI effects settle as the body adapts, especially when meals are kept smaller and lower in fat during the first few weeks.
The combination of reduced brain-level hunger and slower gastric emptying means calorie intake falls, not because the diet is counted to the gram, but because the body's own signals are working more effectively than they were before.
The STEP 1 trial followed adults with obesity who did not have type 2 diabetes for 68 weeks. At the 2.4 mg weekly maintenance dose, participants lost an average of roughly 15% of body weight compared with around 2.4% in the placebo group. Those are averages; some people lose considerably more, others less. The evidence behind Wegovy's weight-loss outcomes discusses how results vary and what factors affect them.
It's also worth knowing that semaglutide is sold under two brand names in the UK with different licences. Wegovy is licensed for weight management. Ozempic carries a licence for type 2 diabetes. The drug is the same; the licensed use is not, and a prescriber assesses which is appropriate. If you want to understand the full picture of how semaglutide fits into weight management specifically, this page on semaglutide and weight loss covers the licensed context in detail.
One thing people sometimes find surprising: when semaglutide stops, the GLP-1 receptor signal goes with it, and for many people appetite returns to its previous level. Studies following participants after they stopped treatment showed a meaningful portion of the weight came back over the following year. This isn't a failure of the person; it reflects how biological appetite regulation works.
NICE recommends Wegovy for up to two years within a specialist weight management setting. Outside that pathway, private prescribers review treatment duration as part of each clinical reassessment. At our clinical team, every repeat order goes through a fresh review, no automatic renewals, no rubber-stamping.
If cost is a factor in your thinking, this honest look at Wegovy pricing explains what legitimate private treatment actually costs and what to watch out for. For everything about the Wegovy injection itself, the Wegovy treatment page is the place to start.
Semaglutide is a prescription-only medicine. If you think it might be suitable for you, the next step is a clinical consultation. Start your free consultation with our prescribers, a real clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.